Recent Quotes
My Watchlist
Indicators
Markets
Stocks
Funds
Tools
Overview
News
Currencies
International
Treasuries

Esperion Theraptc (NQ: ESPR )

25.55 USD -1.20 (-4.49%)
Official Closing Price Updated: 7:58 PM EST, Jan 15, 2021 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Press releases about Esperion Theraptc

< Previous 1 2 3 4 5 6 7 8 9
...
14 15 Next >
The Klein Law Firm Notifies Investors of a Class Action Commenced on Behalf of Esperion Therapeutics, Inc. Shareholders and a Lead Plaintiff Deadline of July 6, 2018 (ESPR)
From ACCESSWIRE
Esperion Therapeutics, Inc. Reminder: Pawar Law Reminds of Important July 6, 2018 Lead Plaintiff Deadline in Class Action- ESPR
From ACCESSWIRE
EQUITY ALERT: Levi & Korsinsky, LLP Reminds Shareholders of Esperion Therapeutics, Inc. of a Class Action Lawsuit and a Lead Plaintiff Deadline of July 6, 2018 - ESPR
From ACCESSWIRE
INVESTOR REMINDER: Kessler Topaz Meltzer & Check, LLP Announces Deadline in Class Action Lawsuit Filed against Esperion Therapeutics, Inc.
The law firm of Kessler Topaz Meltzer & Check, LLP reminds Esperion Therapeutics, Inc. (Nasdaq: ESPR) (“Esperion”) investors that a class action lawsuit has been filed on behalf of purchasers of... 
From Business Wire News Releases
SHAREHOLDER ALERT: Pomerantz Law Firm Reminds Shareholders with Losses on their Investment in Esperion Therapeutics, Inc. of Class Action Lawsuit and Upcoming Deadline – ESPR
From ACCESSWIRE
ESPR INVESTOR ALERT: The Law Offices of Vincent Wong Notifies Investors of a Class Action Involving Esperion Therapeutics, Inc. and a Lead Plaintiff Deadline of July 6, 2018
From ACCESSWIRE
New Research Coverage Highlights Esperion Therapeutics, Magna International, Spectra Energy Partners, LP, Toronto Dominion Bank, Flex, and Yirendai — Consolidated Revenues, Company Growth, and Expecta
In new independent research reports released early this morning, Fundamental Markets released its latest key findings for all current investors, traders, and shareholders of Esperion Therapeutics, Inc.... 
From GlobeNewswire News Releases
ESPR NEWS ALERT: Rosen Law Announces Filing of Securities Class Action Lawsuit Against Esperion Therapeutics, Inc. – ESPR
Rosen Law Firm, a global investor rights law firm, announces the filing of a class action lawsuit on behalf of purchasers of the securities of Esperion Therapeutics, Inc. (NASDAQ:ESPR) from February... 
From GlobeNewswire News Releases
INVESTOR ALERT: Levi & Korsinsky, LLP Notifies Shareholders of Esperion Therapeutics, Inc. of a Class Action Lawsuit and a Lead Plaintiff Deadline of July 6, 2018 - ESPR
From ACCESSWIRE
WeissLaw LLP: Esperion Therapeutics, Inc. is the Subject of a Legal Investigation
WeissLaw LLP, a national class action, shareholder rights law firm with offices in New York, Los Angeles, and Atlanta, announces an investigation of Esperion Therapeutics, Inc. (the "Company" or... 
From PR Newswire
SHAREHOLDER ALERT - Bronstein, Gewirtz & Grossman, LLC Reminds Investors of Class Action Against Esperion Therapeutics, Inc. (ESPR) & Lead Plaintiff Deadline: July 6, 2018
From ACCESSWIRE
SHAREHOLDER ALERT: Pomerantz Law Firm Reminds Shareholders with Losses on their Investment in Esperion Therapeutics, Inc. of Class Action Lawsuit and Upcoming Deadline - ESPR
From ACCESSWIRE
Kessler Topaz Meltzer & Check, LLP Reminds Esperion Therapeutics, Inc. Investors of Important Deadline in Class Action Lawsuit
From ACCESSWIRE
The Klein Law Firm Reminds Investors of a Class Action Commenced on Behalf of Esperion Therapeutics, Inc. Shareholders and a Lead Plaintiff Deadline of July 6, 2018 (ESPR)
The Klein Law Firm reminds investors that a class action complaint has been filed on behalf of shareholders of Esperion Therapeutics, Inc. 
From Business Wire News Releases
Esperion to Participate in Fireside Chat at the Jefferies 2018 Global Healthcare Conference
Esperion (NASDAQ:ESPR), the Lipid Management Company focused on developing and commercializing complementary, convenient, cost-effective, once-daily, oral therapies for the treatment of patients with... 
From GlobeNewswire News Releases
ESPR ALERT: Pawar Law Reminds of Important July 6, 2018 Lead Plaintiff Deadline in Class Action- ESPR
From ACCESSWIRE
Esperion Announces the Appointment of Jay P. Shepard to Board of Directors
Esperion (NASDAQ:ESPR), the Lipid Management Company focused on developing and commercializing complementary, convenient, cost-effective, once-daily, oral therapies for the treatment of patients with... 
From GlobeNewswire News Releases
ESPR EQUITY ALERT: The Law Offices of Vincent Wong Reminds Investors of a Class Action Involving Esperion Therapeutics, Inc. and a Lead Plaintiff Deadline of July 6, 2018
The Law Offices of Vincent Wong reminds Esperion Therapeutics shareholders of a class action lawsuit. 
From Business Wire News Releases
DEADLINE NOTICE: Shareholder Class Action Lawsuit Filed Against Esperion Therapeutics, Inc. – ESPR
From ACCESSWIRE
SHAREHOLDER ALERT: Pomerantz Law Firm Reminds Shareholders with Losses on their Investment in Esperion Therapeutics, Inc. of Class Action Lawsuit and Upcoming Deadline - ESPR
From ACCESSWIRE
Esperion Announces Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)
Esperion (NASDAQ:ESPR), the Lipid Management Company focused on developing and commercializing complementary, convenient, cost-effective, once-daily, oral therapies for the treatment of patients with... 
From GlobeNewswire News Releases
INVESTOR ALERT: Kirby McInerney LLP Advises Esperion Therapeutics, Inc. (ESPR) Investors of Potential Claims
The law firm of Kirby McInerney LLP announced today that a class action lawsuit has been filed in the United States District Court for the Eastern District of Michigan, against Esperion Therapeutics,... 
From Business Wire News Releases
EQUITY ALERT: Levi & Korsinsky, LLP Reminds Shareholders of Esperion Therapeutics, Inc. of a Class Action Lawsuit and a Lead Plaintiff Deadline of July 6, 2018
Levi & Korsinsky reminds Esperion shareholders of a class action lawsuit. 
From Business Wire News Releases
SHAREHOLDER ALERT - Bronstein, Gewirtz & Grossman, LLC Reminds Investors of Class Action Against Esperion Therapeutics, Inc. (ESPR) & Lead Plaintiff Deadline - July 6, 2018
From ACCESSWIRE
The Klein Law Firm Announces a Class Action Commenced on Behalf of Esperion Therapeutics, Inc. Shareholders and a Lead Plaintiff Deadline of July 6, 2018 (ESPR)
The Klein Law Firm announces that a class action complaint has been filed on behalf of shareholders of Esperion Therapeutics, Inc. 
From Business Wire News Releases
Kessler Topaz Meltzer & Check, LLP - Important Deadline Reminder For Esperion Therapeutics, Inc. Investors
The law firm of Kessler Topaz Meltzer & Check, LLP reminds Esperion Therapeutics, Inc. (Nasdaq:ESPR) (“Esperion”) investors that a class action lawsuit has been filed in the United States District... 
From GlobeNewswire News Releases
The Klein Law Firm Announces a Class Action Filed on Behalf of Esperion Therapeutics, Inc. Shareholders and a Lead Plaintiff Deadline of July 6, 2018 (ESPR)
The Klein Law Firm announces that a class action complaint has been filed on behalf of shareholders of Esperion Therapeutics, Inc. (NASDAQ:ESPR) who purchased shares between February 22, 2017 and May... 
From GlobeNewswire News Releases
SHAREHOLDER ALERT: Pomerantz Law Firm Reminds Shareholders with Losses on their Investment in Esperion Therapeutics, Inc. of Class Action Lawsuit and Upcoming Deadline – ESPR
Pomerantz LLP announces that a class action lawsuit has been filed against Esperion Therapeutics, Inc. (“Esperion” or the “Company”) (NASDAQ:ESPR) and certain of its officers. The class action, filed... 
From GlobeNewswire News Releases
Esperion Announces Third Pivotal Phase 3 Study of Bempedoic Acid Meets Primary Endpoint
Esperion (NASDAQ:ESPR), the Lipid Management Company focused on developing and commercializing complementary, convenient, cost-effective, once-daily, oral therapies for the treatment of patients with... 
From GlobeNewswire News Releases
ESPR INVESTOR ALERT: The Law Offices of Vincent Wong Notifies Investors of a Class Action Involving Esperion Therapeutics, Inc. and a Lead Plaintiff Deadline of July 6, 2018
The Law Offices of Vincent Wong announce that a class action lawsuit has been commenced on behalf of Esperion Therapeutics, Inc. shareholders. 
From Business Wire News Releases
< Previous 1 2 3 4 5 6 7 8 9
...
14 15 Next >
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.